Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Apr 18 2002
WASHINGTON, D.C. (April 18, 2002) - More than 250 representatives from more than 160 companies have registered to attend the first BIO-Windhover Partnering...
Apr 16 2002
Washington, D.C. (April 16, 2002)-Mitchel Sayare, Ph.D., president, CEO and chairman of ImmunoGen Inc., will testify Wednesday, April 17, on BIO’s behalf...
Apr 15 2002
WASHINGTON, D.C. (April 15, 2002) - On Saturday, June 1, at the Ontario Science Centre, the Biotechnology Industry Organization (BIO) will host HealthFest 2002...
Apr 15 2002
WASHINGTON, DC – (April 15, 2002) – The Biotechnology Industry Organization (BIO) today honored Florida State Senator Ron Klein(D-Boca Raton) as...
Apr 12 2002
WASHINGTON, D.C. (April 12, 2002) - The three-day policy/ethics track at the Biotechnology Industry Organization’s (BIO) 16th Annual International...
Apr 10 2002
Washington, D.C. (April 10, 2002)-Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today in...
Apr 8 2002
WASHINGTON, D.C. (April 8, 2002)-In an effort to augment homeland security and national defense, the Biotechnology Industry Organization (BIO) is hosting an...
Apr 4 2002
WASHINGTON, D.C. (April 4, 2002) – The Biotechnology Industry Organization (BIO) has joined with a leading health-care business information provider, Windhover...
Mar 28 2002
WASHINGTON (March 28, 2002) -- (Dr. Michael P. Phillips, executive director for food and agriculture of the Biotechnology Industry Organization (BIO) issued...


Biotechnology News

September 22, 2014

OSLO, Norway--(BUSINESS WIRE)--Reference is made to the announcement published on 16 September 2014 in which Nordic Nanovector AS (the “Company”) announced the final...

September 22, 2014

PARIS--(BUSINESS WIRE)--NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of...

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.